$KBIO Key Milestones for 2014-2015 2H 2014: Full enrollment of KB001-A CF Phase 2 study (completed in July 2014) Q4 2014: December 2014: Completion of enrollment in at least one indication in the Phase 2 expansion portion of our KB004 study in hematologic malignancies KB004 Phase 1 study poster presentation at the American Society of Hematology Annual Meeting January 2015: Top line KB001-A CF Phase 2 study results